Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients

Background: The ESE-ENSAT guidelines on the management of adrenocortical carcinoma (ACC) suggest adjuvant mitotane for patients at high risk of recurrence following radical surgery. This indication has a limited evidence base, lacking results from randomized controlled trials. No suggestion for or a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Endocr Soc
Auteurs principaux: Terzolo, Massimo, Fassnacht, Martin, Perotti, Paola, Libe, Rossella, Lacroix, André, Kastelan, Darko, Haak, Harm Reinout, Arlt, Wiebke, Loli, Paola, Decoudier, Bénédicte, Lasolle, Helene, Bancos, Irina, Quinkler, Marcus, Villares Fragoso, Maria Candida Barisson, Canu, Letizia, Puglisi, Soraya, Kroiss, Matthias, Dusek, Tina, Bourdeau, Isabelle, Baudin, Eric, Berchialla, Paola, Beuschlein, Felix, Bertherat, Jerome Yves, Berruti, Alfredo
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Adrenal
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265733/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.336
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires